European Healthtech startup funding raised during H2 2015.
In H2 2015, 136 European Healthtech companies raised a combined €1.4B across 141 funding rounds, up 157.0% versus H2 2014. Switzerland led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 23 Aug 2026.
6 exits · €526M disclosed.
| Biotie Therapies | Acquisition | Sep 2015 | €330M |
| WiThings | Acquisition | Dec 2015 | €170M |
| ClipFort | Acquisition | Dec 2015 | €26M |
| €73M |
| ADC Therapeutics | Growth/Late | Sep 2015 | €71M |
| Symphogen | Debt | Oct 2015 | €68M |
| ObsEva | Series B | Nov 2015 | €54M |
| Sanifit | Series C | Sep 2015 | €37M |
| DNAe LTD | Debt | Nov 2015 | €35M |
| Bima | Series C | Jul 2015 | €34M |
| GenSight Biologics | Series B | Jul 2015 | €32M |
| NightstaRx | Series B | Nov 2015 | €32M |
| Biom'Up | Series C | Sep 2015 | €31M |
| Therachon | Series A | Sep 2015 | €31M |
| PREP Biopharm | Series A | Nov 2015 | €29M |